The collaboration will focus on co-developing new clinical tests and offering current Mayo tests to health care providers and patients in China.
SAN FRANCISCO and SHANGHAI, Jan. 9, 2018 /PRNewswire/ —WuXi AppTec Group and Mayo Clinicannounced today a joint venture to co-develop and deliver clinical diagnostic services inChina. With WuXi AppTec Group's operational excellence and Mayo Medical Laboratories' clinical and laboratory testing expertise, the new joint venture will accelerate the development of novel esoteric tests that both organizations will offer in their respective markets, with the intent to benefit not only patients inChinabut around the world.
"We are excited to work with Mayo Clinic to bring a highly innovative, world-class diagnostics testing portfolio to China," says Jason Liu, Ph.D., senior vice president of WuXi AppTec Group, and chief operating officer of the company's laboratory testing division. "This collaboration is a great fit with our mission to bring the best testing solutions from research to clinical practice. As one of the most highly regarded medical institutions in the world, Mayo Clinic will help transform China's diagnostic landscape, improve the quality of patient care, and accelerate precision medicine in China."
"The strategic collaboration with Mayo Clinic is an important step forward to fulfill WuXi AppTec Group's dream that every drug can be made, every disease can be treated," says Dr. Ge Li, chairman of WuXi AppTec Group. "Through the collaboration with Mayo, we're committed to building a leading diagnostic services operation in China and co-developing in ways that will benefit our patients, doctors, and innovative collaborators in all corners of the world."
WuXi AppTec Group and Mayo Clinic Form Joint Venture
About Mayo Medical Laboratories and the Department of Laboratory Medicine and Pathology TheMayo Clinic Department of Laboratory Medicine and Pathologyand its reference laboratoryMayo Medical Laboratoriesprovide advanced laboratory testing and pathology services to support 4,000 health care organizations around the world. Revenue from this testing supports medical education and research at Mayo Clinic, a nonprofit worldwide leader in medical care, research and education for people from all walks of life. Complemented by collaborations with diagnostic and biotechnology companies, the department maintains a robust diagnostic test-development program, launching more than 100 new tests each year.
About Mayo Clinic Mayo Clinic is a nonprofit organization committed to clinical practice, education, and research, providing expert, comprehensive care to everyone who needs healing. For more information, visit www.mayoclinic.org.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.